With the success of GLP-1-based drugs, pharmaceutical companies are aggressively pursuing next-generation versions that could provide patients with more refined options for controlling diabetes and ...

Millions more Americans will likely donate to nonprofits as a result of changes to tax laws, but those changes will also likely reduce the overall amount of money given to charity. That's according ...

After all the indecision that has surrounded Mizzou over the last few weeks, the Tigers received the ultimate gift from the ...

As anxieties about catastrophes and supply chain disruptions spread across the internet, consumers are flocking to an unexpected source for preparedness: Costco. The warehouse giant is offering $3,000 ...

It is considered to be, as the company calls it, “the upstart audio brand for radio imaging effects.” AUDITORY FX has gained a reputation thanks to the efforts of Steve Stone Voiceovers. Now it has ...

Novo Nordisk announced its CagriSema GLP-1 weight loss drug underperformed Eli Lilly's tirzepatide in a trial. Separately, Lilly announced patients can use a single injector to hold a month's supply ...

Sales of Lilly's GLP-1 drugs are surging. Management issued a bullish profit forecast. Shares of Eli Lilly (NYSE: LLY) climbed over 10% on Wednesday after the medicine maker delivered a blockbuster ...

A compact pocket survival kit review proving small kits can still perform effectively. Judge rules Trump administration unlawfully refused to request CFPB funding Nebraska declares state of emergency ...

Eli Lilly said it will spend $3.5 billion to build a manufacturing plant in Pennsylvania's Lehigh Valley that will help make its next-generation obesity drugs. That includes a closely watched ...

One of the only things that hasn’t changed in the last century of cinema is film’s fascination with being marooned on a deserted island. The last five years alone have seen the release of Triangle Of ...